|
Name |
Phomopsinone B
|
Molecular Formula | C12H16O5 | |
IUPAC Name* |
(7S)-7-[(2R)-2-hydroxypropyl]-4-methoxy-7,8-dihydro-5H-pyrano[4,3-b]pyran-2-one
|
|
SMILES |
C[C@H](C[C@H]1CC2=C(CO1)C(=CC(=O)O2)OC)O
|
|
InChI |
InChI=1S/C12H16O5/c1-7(13)3-8-4-11-9(6-16-8)10(15-2)5-12(14)17-11/h5,7-8,13H,3-4,6H2,1-2H3/t7-,8+/m1/s1
|
|
InChIKey |
LVPYBBRMUJCOKG-SFYZADRCSA-N
|
|
Synonyms |
Phomopsinone B; CHEMBL3889733
|
|
CAS | NA | |
PubChem CID | 57387252 | |
ChEMBL ID | CHEMBL3889733 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 240.25 | ALogp: | -0.1 |
HBD: | 1 | HBA: | 5 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 65.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 17 | QED Weighted: | 0.861 |
Caco-2 Permeability: | -4.81 | MDCK Permeability: | 0.00006460 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.628 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.017 |
30% Bioavailability (F30%): | 0.988 |
Blood-Brain-Barrier Penetration (BBB): | 0.131 | Plasma Protein Binding (PPB): | 25.32% |
Volume Distribution (VD): | 0.979 | Fu: | 60.44% |
CYP1A2-inhibitor: | 0.3 | CYP1A2-substrate: | 0.918 |
CYP2C19-inhibitor: | 0.05 | CYP2C19-substrate: | 0.82 |
CYP2C9-inhibitor: | 0.019 | CYP2C9-substrate: | 0.193 |
CYP2D6-inhibitor: | 0.014 | CYP2D6-substrate: | 0.625 |
CYP3A4-inhibitor: | 0.012 | CYP3A4-substrate: | 0.27 |
Clearance (CL): | 9.084 | Half-life (T1/2): | 0.775 |
hERG Blockers: | 0.029 | Human Hepatotoxicity (H-HT): | 0.932 |
Drug-inuced Liver Injury (DILI): | 0.78 | AMES Toxicity: | 0.551 |
Rat Oral Acute Toxicity: | 0.309 | Maximum Recommended Daily Dose: | 0.948 |
Skin Sensitization: | 0.301 | Carcinogencity: | 0.932 |
Eye Corrosion: | 0.007 | Eye Irritation: | 0.099 |
Respiratory Toxicity: | 0.887 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003165 | 0.704 | D09PJX | 0.261 | ||||
ENC003018 | 0.679 | D09GYT | 0.225 | ||||
ENC001413 | 0.400 | D03SKD | 0.217 | ||||
ENC002732 | 0.391 | D02XJY | 0.215 | ||||
ENC005637 | 0.388 | D07MGA | 0.213 | ||||
ENC001982 | 0.381 | D0J4IX | 0.211 | ||||
ENC003474 | 0.364 | D0S5CH | 0.211 | ||||
ENC005388 | 0.358 | D0X5KF | 0.209 | ||||
ENC003859 | 0.358 | D08SKH | 0.208 | ||||
ENC002512 | 0.358 | D03GCJ | 0.207 |